Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization

BACKGROUND: The Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how the dynamics of clinical progression changed alon...

Descripción completa

Detalles Bibliográficos
Autores principales: Fintzi, Jonathan, Bonnett, Tyler, Sweeney, Daniel A, Huprikar, Nikhil A, Ganesan, Anuradha, Frank, Maria G, McLellan, Susan L F, Dodd, Lori E, Tebas, Pablo, Mehta, Aneesh K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499739/
https://www.ncbi.nlm.nih.gov/pubmed/34409989
http://dx.doi.org/10.1093/cid/ciab712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499739/
https://www.ncbi.nlm.nih.gov/pubmed/34409989
http://dx.doi.org/10.1093/cid/ciab712

Ejemplares similares